The p.G1186S variant (also known as c.3556G>A), located in coding exon 6 of the MSH6 gene, results from a G to A substitution at nucleotide position 3556. The glycine at codon 1186 is replaced by serine, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 6 and may have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. This amino acid position is highly conserved in available vertebrate species. In addition, as a missense substitution this is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
ClinVar Genomic variation as it relates to human health
NM_000179.3(MSH6):c.3556G>A (p.Gly1186Ser)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(1)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
1
criteria provided, single submitter
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000179.3(MSH6):c.3556G>A (p.Gly1186Ser)
Variation ID: 2587318 Accession: VCV002587318.2
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2p16.3 2: 47805027 (GRCh38) [ NCBI UCSC ] 2: 48032166 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 28, 2023 May 1, 2024 Jun 15, 2023 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_000179.3:c.3556G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000170.1:p.Gly1186Ser missense NM_001281492.2:c.3166G>A NP_001268421.1:p.Gly1056Ser missense NM_001281493.2:c.2650G>A NP_001268422.1:p.Gly884Ser missense NM_001281494.2:c.2650G>A NP_001268423.1:p.Gly884Ser missense NM_001406795.1:c.3652G>A NP_001393724.1:p.Gly1218Ser missense NM_001406796.1:c.3556G>A NP_001393725.1:p.Gly1186Ser missense NM_001406797.1:c.3259G>A NP_001393726.1:p.Gly1087Ser missense NM_001406798.1:c.3382G>A NP_001393727.1:p.Gly1128Ser missense NM_001406799.1:c.3031G>A NP_001393728.1:p.Gly1011Ser missense NM_001406800.1:c.3556G>A NP_001393729.1:p.Gly1186Ser missense NM_001406801.1:c.3259G>A NP_001393730.1:p.Gly1087Ser missense NM_001406802.1:c.3652G>A NP_001393731.1:p.Gly1218Ser missense NM_001406803.1:c.2692G>A NP_001393732.1:p.Gly898Ser missense NM_001406804.1:c.3478G>A NP_001393733.1:p.Gly1160Ser missense NM_001406805.1:c.3259G>A NP_001393734.1:p.Gly1087Ser missense NM_001406806.1:c.3031G>A NP_001393735.1:p.Gly1011Ser missense NM_001406807.1:c.3031G>A NP_001393736.1:p.Gly1011Ser missense NM_001406808.1:c.3556G>A NP_001393737.1:p.Gly1186Ser missense NM_001406809.1:c.3556G>A NP_001393738.1:p.Gly1186Ser missense NM_001406811.1:c.2650G>A NP_001393740.1:p.Gly884Ser missense NM_001406812.1:c.2650G>A NP_001393741.1:p.Gly884Ser missense NM_001406813.1:c.3562G>A NP_001393742.1:p.Gly1188Ser missense NM_001406814.1:c.2650G>A NP_001393743.1:p.Gly884Ser missense NM_001406815.1:c.2650G>A NP_001393744.1:p.Gly884Ser missense NM_001406816.1:c.2650G>A NP_001393745.1:p.Gly884Ser missense NM_001406817.1:c.1990G>A NP_001393746.1:p.Gly664Ser missense NM_001406818.1:c.3259G>A NP_001393747.1:p.Gly1087Ser missense NM_001406819.1:c.3259G>A NP_001393748.1:p.Gly1087Ser missense NM_001406820.1:c.3259G>A NP_001393749.1:p.Gly1087Ser missense NM_001406821.1:c.3259G>A NP_001393750.1:p.Gly1087Ser missense NM_001406822.1:c.3259G>A NP_001393751.1:p.Gly1087Ser missense NM_001406823.1:c.2650G>A NP_001393752.1:p.Gly884Ser missense NM_001406824.1:c.3259G>A NP_001393753.1:p.Gly1087Ser missense NM_001406825.1:c.3259G>A NP_001393754.1:p.Gly1087Ser missense NM_001406826.1:c.3388G>A NP_001393755.1:p.Gly1130Ser missense NM_001406827.1:c.3259G>A NP_001393756.1:p.Gly1087Ser missense NM_001406828.1:c.3259G>A NP_001393757.1:p.Gly1087Ser missense NM_001406829.1:c.2650G>A NP_001393758.1:p.Gly884Ser missense NM_001406830.1:c.3259G>A NP_001393759.1:p.Gly1087Ser missense NM_001406831.1:c.337G>A NP_001393760.1:p.Gly113Ser missense NM_001406832.1:c.403G>A NP_001393761.1:p.Gly135Ser missense NM_001407362.1:c.1501G>A NP_001394291.1:p.Gly501Ser missense NR_176256.1:n.2486G>A non-coding transcript variant NR_176257.1:n.3817G>A non-coding transcript variant NR_176258.1:n.3746G>A non-coding transcript variant NR_176259.1:n.3645G>A non-coding transcript variant NR_176260.1:n.1590G>A NC_000002.12:g.47805027G>A NC_000002.11:g.48032166G>A NG_007111.1:g.26881G>A NG_008397.1:g.105649C>T LRG_219:g.26881G>A LRG_219t1:c.3556G>A LRG_219p1:p.Gly1186Ser - Protein change
- G1056S, G1130S, G113S, G1160S, G884S, G1087S, G135S, G1011S, G1128S, G1186S, G501S, G664S, G1188S, G1218S, G898S
- Other names
- -
- Canonical SPDI
- NC_000002.12:47805026:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| MSH6 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
9161 | 9479 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
Jun 15, 2023 | RCV003360799.2 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(Jun 15, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV004055242.2
First in ClinVar: Oct 28, 2023 Last updated: May 01, 2024 |
Comment:
The p.G1186S variant (also known as c.3556G>A), located in coding exon 6 of the MSH6 gene, results from a G to A substitution at nucleotide … (more)
The p.G1186S variant (also known as c.3556G>A), located in coding exon 6 of the MSH6 gene, results from a G to A substitution at nucleotide position 3556. The glycine at codon 1186 is replaced by serine, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 6 and may have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. This amino acid position is highly conserved in available vertebrate species. In addition, as a missense substitution this is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)
|
Comment:
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
The p.G1186S variant (also known as c.3556G>A), located in coding exon 6 of the MSH6 gene, results from a G to A substitution at nucleotide position 3556. The glycine at codon 1186 is replaced by serine, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 6 and may have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. This amino acid position is highly conserved in available vertebrate species. In addition, as a missense substitution this is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 01, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.